These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30925452)

  • 21. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.
    Zhao M; Maani N; Dowling JJ
    Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
    Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BIN1 modulation in vivo rescues dynamin-related myopathy.
    Lionello VM; Kretz C; Edelweiss E; Crucifix C; Gómez-Oca R; Messaddeq N; Buono S; Koebel P; Massana Muñoz X; Diedhiou N; Cowling BS; Bitoun M; Laporte J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.
    Park YE; Choi YC; Bae JS; Lee CH; Kim HS; Shin JH; Kim DS
    J Clin Neurol; 2014 Jan; 10(1):24-31. PubMed ID: 24465259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
    Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
    Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.
    Durieux AC; Vassilopoulos S; Lainé J; Fraysse B; Briñas L; Prudhon B; Castells J; Freyssenet D; Bonne G; Guicheney P; Bitoun M
    Traffic; 2012 Jun; 13(6):869-79. PubMed ID: 22369075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gain-of-Function Properties of a Dynamin 2 Mutant Implicated in Charcot-Marie-Tooth Disease.
    Tassin TC; Barylko B; Hedde PN; Chen Y; Binns DD; James NG; Mueller JD; Jameson DM; Taussig R; Albanesi JP
    Front Cell Neurosci; 2021; 15():745940. PubMed ID: 34744632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic mechanisms in centronuclear myopathies.
    Jungbluth H; Gautel M
    Front Aging Neurosci; 2014; 6():339. PubMed ID: 25566070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
    Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
    González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
    Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy.
    Abath Neto O; Martins Cde A; Carvalho M; Chadi G; Seitz KW; Oliveira AS; Reed UC; Laporte J; Zanoteli E
    Genet Mol Biol; 2015 May; 38(2):147-51. PubMed ID: 26273216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
    Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
    Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.